$NBIX
NEUROCRINE BIOSCIENCES INC

2019 Q3 Form 10-Q Financial Statement

#000156459019039803 Filed on November 04, 2019

View on sec.gov

Income Statement

Concept 2019 Q3 2018 Q4 2018 Q3
Revenue $222.1M $131.5M $151.8M
YoY Change 46.35% 39.12% 149.71%
Cost Of Revenue $2.200M $1.500M $1.600M
YoY Change 37.5% 87.5% 269.52%
Gross Profit $219.9M $130.0M $150.2M
YoY Change 46.4% 38.59% 148.92%
Gross Profit Margin 99.01% 98.87% 98.97%
Selling, General & Admin $84.50M $69.00M $60.40M
YoY Change 39.9% 22.56% 37.67%
% of Gross Profit 38.43% 53.08% 40.21%
Research & Development $45.30M $39.10M $35.48M
YoY Change 27.67% 52.73% 57.96%
% of Gross Profit 20.6% 30.08% 23.62%
Depreciation & Amortization $2.000M $1.300M $1.000M
YoY Change 100.0% 85.71% 66.67%
% of Gross Profit 0.91% 1.0% 0.67%
Operating Expenses $132.0M $109.6M $97.43M
YoY Change 35.48% 32.58% 45.93%
Operating Profit $90.10M $20.38M $54.32M
YoY Change 65.86% 83.31% -1006.14%
Interest Expense $8.000M -$3.100M $7.672M
YoY Change 4.28% -39.22% 4.57%
% of Operating Profit 8.88% -15.21% 14.12%
Other Income/Expense, Net -$31.70M -$3.559M
YoY Change 790.7% -30.62%
Pretax Income $58.40M $18.80M $50.76M
YoY Change 15.04% 172.46% -557.33%
Income Tax $4.600M $700.0K
% Of Pretax Income 7.88% 3.72%
Net Earnings $53.80M $18.08M $50.76M
YoY Change 5.98% 162.23% -556.31%
Net Earnings / Revenue 24.22% 13.75% 33.45%
Basic Earnings Per Share $0.59 $0.20 $0.56
Diluted Earnings Per Share $0.56 $0.19 $0.52
COMMON SHARES
Basic Shares Outstanding 91.90M shares 90.74M 90.56M
Diluted Shares Outstanding 96.10M shares 95.72M 96.80M

Balance Sheet

Concept 2019 Q3 2018 Q4 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $670.2M $650.9M $635.3M
YoY Change 5.49% 26.16% 24.32%
Cash & Equivalents $166.6M $141.7M $201.2M
Short-Term Investments $503.5M $509.2M $439.6M
Other Short-Term Assets $22.95M $18.59M $18.90M
YoY Change 21.45% 171.88% 155.16%
Inventory $10.80M $10.86M $6.100M
Prepaid Expenses
Receivables $115.3M $57.41M $54.10M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $819.2M $737.8M $714.4M
YoY Change 14.67% 32.95% 30.25%
LONG-TERM ASSETS
Property, Plant & Equipment $40.30M $33.87M $28.62M
YoY Change 40.83% 213.28% 213.11%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $253.7M $216.0M $185.3M
YoY Change 36.91% -12.69% -11.89%
Other Assets $4.700M $5.500M $5.500M
YoY Change -14.55% 22.22% 19.57%
Total Long-Term Assets $360.7M $255.4M $219.3M
YoY Change 64.44% -2.78% -2.08%
TOTAL ASSETS
Total Short-Term Assets $819.2M $737.8M $714.4M
Total Long-Term Assets $360.7M $255.4M $219.3M
Total Assets $1.180B $993.2M $933.7M
YoY Change 26.37% 21.47% 20.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $102.4M $13.80M $72.00M
YoY Change 42.22% 144.35% 93.03%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $383.6M
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $115.7M $88.23M $456.4M
YoY Change -74.66% 62.12% 1096.61%
LONG-TERM LIABILITIES
Long-Term Debt $403.6M $388.5M $0.00
YoY Change 5.11% -100.0%
Other Long-Term Liabilities $11.70M $35.66M $29.80M
YoY Change -60.75% 26271.68%
Total Long-Term Liabilities $11.70M $35.66M $29.80M
YoY Change -60.75% 26271.68%
TOTAL LIABILITIES
Total Short-Term Liabilities $115.7M $88.23M $456.4M
Total Long-Term Liabilities $11.70M $35.66M $29.80M
Total Liabilities $605.4M $512.4M $486.2M
YoY Change 24.51% 15.03% 14.41%
SHAREHOLDERS EQUITY
Retained Earnings -$1.167B -$1.178B -$1.196B
YoY Change -2.44% -1.76% -0.82%
Common Stock $1.740B $1.660B $1.645B
YoY Change 5.73% 5.57% 5.89%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $574.5M $480.8M $447.5M
YoY Change
Total Liabilities & Shareholders Equity $1.180B $993.2M $933.7M
YoY Change 26.37% 21.47% 20.87%

Cashflow Statement

Concept 2019 Q3 2018 Q4 2018 Q3
OPERATING ACTIVITIES
Net Income $53.80M $18.08M $50.76M
YoY Change 5.98% 162.23% -556.31%
Depreciation, Depletion And Amortization $2.000M $1.300M $1.000M
YoY Change 100.0% 85.71% 66.67%
Cash From Operating Activities $97.80M $50.50M $68.90M
YoY Change 41.94% 24.38% -840.86%
INVESTING ACTIVITIES
Capital Expenditures -$3.500M -$6.000M -$12.40M
YoY Change -71.77% 160.87% 342.86%
Acquisitions
YoY Change
Other Investing Activities -$82.10M -$100.2M -$32.80M
YoY Change 150.3% 74.87% 0.61%
Cash From Investing Activities -$85.60M -$106.2M -$45.10M
YoY Change 89.8% 77.89% 27.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 13.10M 1.800M 5.400M
YoY Change 142.59% -67.86% 80.0%
NET CHANGE
Cash From Operating Activities 97.80M 50.50M 68.90M
Cash From Investing Activities -85.60M -106.2M -45.10M
Cash From Financing Activities 13.10M 1.800M 5.400M
Net Change In Cash 25.30M -53.90M 29.20M
YoY Change -13.36% 299.26% -170.02%
FREE CASH FLOW
Cash From Operating Activities $97.80M $50.50M $68.90M
Capital Expenditures -$3.500M -$6.000M -$12.40M
Free Cash Flow $101.3M $56.50M $81.30M
YoY Change 24.6% 31.7% -1350.77%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-5805000
dei Document Transition Report
DocumentTransitionReport
false
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity File Number
EntityFileNumber
0-22705
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0525145
dei Entity Address Address Line1
EntityAddressAddressLine1
12780 El Camino Real
CY2019Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92130
dei City Area Code
CityAreaCode
858
dei Local Phone Number
LocalPhoneNumber
617-7600
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
141714000
CY2019Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
503525000
CY2019Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
115318000
CY2019Q3 us-gaap Inventory Net
InventoryNet
10798000
CY2018Q4 us-gaap Inventory Net
InventoryNet
10864000
CY2018Q4 us-gaap Other Assets Current
OtherAssetsCurrent
18594000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
737777000
CY2019Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
4706000
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
5477000
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
40302000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
33869000
CY2019Q3 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
204793000
CY2018Q4 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
216028000
CY2019Q3 us-gaap Equity Securities Fv Ni Restricted
EquitySecuritiesFvNiRestricted
48915000
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
61987000
CY2019Q3 us-gaap Assets
Assets
1179935000
CY2018Q4 us-gaap Assets
Assets
993151000
CY2019Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
102357000
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
86377000
CY2019Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
13295000
CY2018Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1856000
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
115652000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
88233000
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
74482000
CY2019Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
403589000
CY2018Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
388496000
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Shell Company
EntityShellCompany
false
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
166637000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
509199000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
57406000
CY2019Q3 us-gaap Other Assets Current
OtherAssetsCurrent
22954000
CY2019Q3 us-gaap Assets Current
AssetsCurrent
819232000
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
91000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1660361000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1932000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1177755000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
480765000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
993151000
CY2019Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
11697000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
10231000
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
18114000
CY2018Q4 nbix Deferred Gain On Sale Of Real Estate Noncurrent
DeferredGainOnSaleOfRealEstateNoncurrent
7312000
CY2019Q3 us-gaap Liabilities
Liabilities
605420000
CY2018Q4 us-gaap Liabilities
Liabilities
512386000
CY2019Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
220000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
220000000
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
92080000
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
92080000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
90797000
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
90797000
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
92000
CY2019Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1739517000
CY2019Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1606000
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1166700000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
574515000
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1179935000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
319748000
nbix Cost Of Sales
CostOfSales
4966000
nbix Cost Of Sales
CostOfSales
3355000
CY2018Q3 nbix Research And Development Expense Excluding Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
35482000
nbix Research And Development Expense Excluding Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
144617000
nbix Research And Development Expense Excluding Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
121417000
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
118081000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
252851000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
179952000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
97434000
us-gaap Operating Expenses
OperatingExpenses
520515000
us-gaap Operating Expenses
OperatingExpenses
304724000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
90098000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
54323000
us-gaap Operating Income Loss
OperatingIncomeLoss
23562000
us-gaap Operating Income Loss
OperatingIncomeLoss
15024000
CY2019Q3 us-gaap Interest Expense
InterestExpense
8038000
CY2018Q3 us-gaap Interest Expense
InterestExpense
7672000
us-gaap Interest Expense
InterestExpense
23833000
us-gaap Interest Expense
InterestExpense
22767000
CY2018Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
753000
CY2019Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-28450000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
3538000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6550000
us-gaap Net Income Loss
NetIncomeLoss
3033000
CY2019Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
961000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-5805000
CY2019Q3 nbix Investment Income And Other Net
InvestmentIncomeAndOtherNet
4797000
CY2018Q3 nbix Investment Income And Other Net
InvestmentIncomeAndOtherNet
4113000
nbix Investment Income And Other Net
InvestmentIncomeAndOtherNet
13980000
nbix Investment Income And Other Net
InvestmentIncomeAndOtherNet
10776000
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-31691000
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3559000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-15658000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11991000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
58407000
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
50764000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7904000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3033000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4618000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4892000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
53789000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
50764000
us-gaap Net Income Loss
NetIncomeLoss
3012000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-206000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
54750000
CY2018Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
51517000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2827000
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.52
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91859000
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90555000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91440000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90064000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
96074000
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
96798000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
95231000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
95272000
us-gaap Net Income Loss
NetIncomeLoss
3012000
us-gaap Net Income Loss
NetIncomeLoss
3033000
us-gaap Share Based Compensation
ShareBasedCompensation
53945000
us-gaap Share Based Compensation
ShareBasedCompensation
44800000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5361000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2749000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
14057000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
13040000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1036000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
989000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1466000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1436000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
792000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-482000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
57912000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
23436000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-66000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3907000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
2180000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
2714000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
12344000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
15577000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
14641000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-175000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
49501000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
50910000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
467090000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
329289000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
488823000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
211402000
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
54720000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11936000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18802000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
8000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
30000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-44915000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-136659000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
20029000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
27748000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20029000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
27748000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
24615000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-58001000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
147191000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
259212000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
171806000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
201211000
us-gaap Interest Paid Net
InterestPaidNet
5822000
us-gaap Interest Paid Net
InterestPaidNet
5822000
us-gaap Income Taxes Paid
IncomeTaxesPaid
507000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
55000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1802000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
372138000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-41818000
CY2018Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1847000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19879000
CY2018Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
16135000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
364487000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-5913000
CY2018Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
888000
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11851000
CY2018Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6123000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
377436000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
50764000
CY2018Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
753000
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13070000
CY2018Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5490000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
447513000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
480765000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-102115000
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1699000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15764000
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2581000
CY2019Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2538000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
409275000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
51338000
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
878000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17931000
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4284000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
483706000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
53789000
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
961000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
20250000
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
13164000
CY2019Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2645000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
574515000
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
331622000
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
792000
CY2019Q3 us-gaap Investments
Investments
757233000
CY2018Q4 us-gaap Investments
Investments
725227000
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
245745000
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
1376000
CY2018Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
577367000
CY2018Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
2168000
CY2019Q3 us-gaap Investments
Investments
757233000
CY2018Q4 us-gaap Investments
Investments
725227000
CY2019Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
142545000
CY2019Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
71000
CY2019Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
42451000
CY2019Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
11000
CY2019Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
184996000
CY2019Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
82000
CY2019Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
6461000
CY2018Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
7855000
CY2019Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2249000
CY2018Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2208000
CY2019Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2088000
CY2018Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
801000
CY2019Q3 us-gaap Inventory Net
InventoryNet
10798000
CY2018Q4 us-gaap Inventory Net
InventoryNet
10864000
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
166637000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
141714000
CY2019Q3 us-gaap Other Restricted Assets Current
OtherRestrictedAssetsCurrent
463000
CY2019Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
4706000
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
5477000
CY2019Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
171806000
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
147191000
CY2007Q4 us-gaap Sale Leaseback Transaction Gross Proceeds Investing Activities
SaleLeasebackTransactionGrossProceedsInvestingActivities
109000000.0
CY2007Q4 us-gaap Mortgage Loans On Real Estate Cost Of Mortgages Sold
MortgageLoansOnRealEstateCostOfMortgagesSold
47700000
CY2007Q4 us-gaap Sale Leaseback Transaction Net Proceeds Financing Activities
SaleLeasebackTransactionNetProceedsFinancingActivities
61000000.0
CY2008Q4 us-gaap Sale Leaseback Transaction Deferred Gain Net
SaleLeasebackTransactionDeferredGainNet
39100000
CY2018Q4 us-gaap Sale Leaseback Transaction Deferred Gain Net
SaleLeasebackTransactionDeferredGainNet
8000000.0
CY2007Q4 nbix Number Of Buildings Leased
NumberOfBuildingsLeased
2
CY2007Q4 nbix Sale Leaseback Transaction Lease Period
SaleLeasebackTransactionLeasePeriod
P12Y
CY2007Q4 nbix Number Of Vacated Buildings
NumberOfVacatedBuildings
1
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
82600000
CY2019Q3 nbix Non Cancelable Future Minimum Lease Payments For Operating Leases Not Yet Commenced
NonCancelableFutureMinimumLeasePaymentsForOperatingLeasesNotYetCommenced
47400000
nbix Number Of Buildings Leased
NumberOfBuildingsLeased
1
CY2019Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P12Y
CY2019Q3 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
The 2019 amendment includes two options to extend the term of the lease for a period of 10 years each. We were not reasonably certain to exercise either of these options at lease commencement.
CY2019Q3 nbix Number Of Renewal Options
NumberOfRenewalOptions
2
CY2019Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P10Y
CY2019Q3 us-gaap Deposits
Deposits
700000
us-gaap Operating Lease Cost
OperatingLeaseCost
5900000
us-gaap Operating Lease Payments
OperatingLeasePayments
5500000
CY2019Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P11Y5M4D
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
62000000.0
CY2019Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0584
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2142000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
8431000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
9026000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
9302000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
9586000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
77068000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
115555000
CY2019Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
32914000
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
82641000
CY2019Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8159000
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
74482000
CY2019Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
517500000
CY2018Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
517500000
CY2019Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
7290000
CY2018Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
8326000
CY2019Q3 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
106621000
CY2018Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
120678000
CY2019Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
403589000
CY2018Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
388496000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
53789000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
50764000
us-gaap Net Income Loss
NetIncomeLoss
3012000
us-gaap Net Income Loss
NetIncomeLoss
3033000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91859000
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90555000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91440000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90064000
CY2019Q3 nbix Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Debt Securities
IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities
1277000
CY2018Q3 nbix Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Debt Securities
IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities
2255000
nbix Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Debt Securities
IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities
805000
nbix Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Debt Securities
IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities
1326000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
96074000
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
96798000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
95231000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
95272000
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.52
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03

Files In Submission

Name View Source Status
0001564590-19-039803-index-headers.html Edgar Link pending
0001564590-19-039803-index.html Edgar Link pending
0001564590-19-039803.txt Edgar Link pending
0001564590-19-039803-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nbix-10q_20190930.htm Edgar Link pending
nbix-10q_20190930_htm.xml Edgar Link completed
nbix-20190930.xsd Edgar Link pending
nbix-20190930_cal.xml Edgar Link unprocessable
nbix-20190930_def.xml Edgar Link unprocessable
nbix-20190930_lab.xml Edgar Link unprocessable
nbix-20190930_pre.xml Edgar Link unprocessable
nbix-ex101_32.htm Edgar Link pending
nbix-ex311_6.htm Edgar Link pending
nbix-ex312_9.htm Edgar Link pending
nbix-ex32_7.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending